A decade ago, the American Diabetes Association (ADA) and the American Association of Clinical Endocrinologists (AACE) updated treatment guidelines for hospital patients outside the intensive care ...

For patients with type 2 diabetes who are taking multiple daily insulin injections, switching to combination treatment with basal insulin plus an agent from one of two newer glucose-lowering drug ...

SAN DIEGO—Novo Nordisk is in a tough market race against Sanofi with combo product Xultophy, which hit the market after the French drugmaker’s Soliqua. New basal-bolus topping data, though, could give ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. SAN FRANCISCO — Adults with type 2 diabetes inadequately ...

SAN DIEGO — A single daily injection of fixed-dose insulin degludec/liraglutide (IDegLira) (Xultophy 100/3.6, Novo Nordisk) could offer an alternative to multiple daily insulin injections for patients ...

Hyperglycemia is a marker for poor clinical outcome and mortality in hospitalized patients. In the critical care setting, insulin administered intravenously or subcutaneously is effective.

You can manage type 2 diabetes several ways, including with a healthy diet and regular exercise. But sometimes, you may need insulin and other medication to help control your blood sugar levels. The ...

Please provide your email address to receive an email when new articles are posted on . Weiner: Is insulin pump therapy recommended for people with type 2 diabetes who require basal-bolus therapy?

Diabetes is a condition that interferes with blood sugar levels in people whose bodies don't produce the right amount of insulin — a hormone made in the pancreas. Blood sugar that’s too high ...

COMBINE 3 phase 3a trial successfully completed with once-weekly IcoSema demonstrating non-inferior reduction in HbA1c versus daily basal-bolus treatment (insulin glargine U100 and insulin aspart) in ...

* THIS WAS REPORTED BY PEOPLE WITH TYPE 2 DIABETES WHOSE BLOOD SUGAR WAS NOT CONTROLLED ON INSULIN GLARGINE U100 WITH METFORMIN, AND WHO COMPLETED QUALITY-OF-LIFE QUESTIONNAIRES AS PART OF THE DUAL ...

A real-world study conducted across 9 European countries found that bolus injection frequency and engagement with a smart pen to administer insulin were associated with improved glycemic control among ...